INOVIO to Participate in Upcoming Investor Conferences

PLYMOUTH MEETING, Pa., Nov. 11, 2026 — INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences:

Jefferies Global Healthcare Conference in London
Date: Wednesday, November 18
Time: 12:00 p.m. EST / 5:00 p.m. GMT
Format: Presentation
Webcast: https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/e3gFZPzHNgoxtsxeAwXEr2

Piper Sandler 38^th Annual Healthcare Conference in New York
Date: Tuesday, December 1
Time: 2:00-2:25 p.m. EST
Format: Fireside chat
Webcast: https://event.webcasts.com/starthere.jsp?ei=1782025&tp_key=9cacd40318 

Replays of the presentations will be available for 90 days at the links above. During these conferences members of INOVIO's management team will also be conducting one-on-one meetings with investors.

Contacts
Media: Josephine Galatioto - ICR Healthcare, [email protected]
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, [email protected]

SOURCE INOVIO Pharmaceuticals, Inc.